GHA interview in Sciences Critiques & Alternatives Economiques
As negotiations are coming to a close for the next Multiannual Financial Framework (MFF 2028-2034), the future of European scientific research is also being decided. While the European Commission promises to double the research budget to €175 billion through the upcoming 10th Framework Programme (FP10 or “Horizon Europe”), the budgetary and structural trade-offs are triggering red flags among civil society actors.
In an in-depth investigative piece co-published by Sciences Critiques and Alternatives Économiques, Fanny Voitzwinkler, Development Director at Global Health Advocates France, breaks down this shift by the European Union. By subordinating vital areas like public health, climate, and agriculture to the European Competitiveness Fund, the EU is continuing its market-driven policy. Societal and health challenges risk being sidelined in favor of an exclusive pursuit of economic growth and industrial productivity:
“Research policy is becoming an economic tool only. Strategic thinking does not start with a question about the societal challenges to be met, but with the desire to be internationally competitive. Societal effects are only potential consequences of economic investment.”
From the danger of seeing DG Trade pilot public health projects to the exclusion of neglected diseases due to a lack of commercial profitability (such as tuberculosis), read the full analysis from our Development Director. The FP10 negotiations are almost over: there is only a short time left to mobilise for human-centered, health-focused, and solidary research.
Read the full article here : https://sciences-critiques.fr/le-nouvel-horizon-liberal-de-la-recherche-europeenne/
;
